E. Kienle

Intermittent Complete Androgen Blockade in PSA Relapse after Radical Prostatectomy and Incidental Prostate Cancer

Ralf Kurek, H. Renneberg, G. L uuml bben et al. · European Urology · 1999 · 66 citations

Psa Relapse, Surgical Oncology, Urology +7

Cyclophosphamide, methotrexate and fluorouracil (CMF) versus hormonal ablation with leuprorelin acetate as adjuvant treatment of node-positive, premenopausal breast cancer patients: preliminary results of the TABLE-study (Takeda Adjuvant Breast cancer study with Leuprorelin Acetate).

Peter Schmid, Michael Untch, D. Wallwiener et al. · PubMed · 2002 · 52 citations

Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis

Pedro‐Antonio Regidor, M. Regidor, Mette Schmidt et al. · Gynecological Endocrinology · 2001 · 52 citations

Hormonal Contraceptive, Clinical Symptoms, Fertility +18

Testosterone recovery in the off-treatment time in prostate cancer patients undergoing intermittent androgen deprivation therapy

U. Tunn, G Canepa, A Kochanowsky et al. · Prostate Cancer and Prostatic Diseases · 2012 · 35 citations

Andrology, Urology, Off-treatment Time +2

1458: Intermittent Is as Effective as Continuous Androgen Deprivation in Patients with PSA-Relapse after Radical Prostatectomy (RP)

U. Tunn, Ralf Kurek, E. Kienle et al. · The Journal of Urology · 2004 · 30 citations

Urological Research, Urology, Pm1 Apr 20041458 +15